The effect of esketamine on lung ischemia-reperfusion oxidative stress markers and pulmonary complications in patients undergoing radical surgery for lung cancer
10.3760/cma.j.cn115355-20240522-00256
- VernacularTitle:艾司氯胺酮对肺癌根治术患者肺缺血再灌注氧化应激指标及肺部并发症的影响
- Author:
Juan QI
1
;
Shan WANG
1
;
Lu YU
1
;
Airong ZHANG
1
Author Information
1. 沧州市人民医院麻醉科，沧州 061000
- Publication Type:Journal Article
- Keywords:
Lung neoplasms;
Esketamine;
Ischemia-reperfusion injury;
Oxidative stress;
Adverse reactions
- From:
Cancer Research and Clinic
2025;37(7):493-497
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the effect of esketamine on lung ischemia-reperfusion oxidative stress markers and pulmonary complications in patients undergoing radical surgery for lung cancer.Methods:A prospective randomized-controlled study was conducted. A total of 60 patients undergoing radical lung cancer surgery in Cangzhou People's Hospital from October 2023 to April 2024 were selected as the research objects. The patients were randomly divided into group E (30 cases) and group C (30 cases) according to the envelope drawing method. The patients in group E received an intravenous injection of esketamine at 0.5 mg/kg before skin incision, followed by continuous intravenous infusion until 30 minutes before the end of surgery. The patients in group C was administered an equivalent dose of 0.9% NaCl solution. The lung function, inflammatory factors, oxidative stress markers, and the incidence of complications were compared between the 2 groups at different time intervals [after anesthesia induction (T 1), 60 minutes after single-lung ventilation (T 2), 30 minutes after resuming bilateral lung ventilation (T 3), and 60 minutes after resuming bilateral lung ventilation (T 4)]. Results:The age of patients in both groups was (62±8) years. At T 2, T 3, and T 4, the oxygenation index (OI) of group E [(413±57), (387±52), (364±48) mmHg (1 mmHg = 0.133 kPa), respectively] was higher than that of group C [(377±52), (359±47), (333±42) mmHg, respectively]. The intrapulmonary shunt rate of group E [(26.9±3.3)%, (24.6±3.1)%, (13.3±2.2)%, respectively] was lower than that of group C[(33.5±4.3)%, (28.4±3.7)%, (16.2±2.7)%, respectively], and the differences were statistically significant ( t = 2.56, 2.16, 2.66, 6.29, 4.34, 4.32, respectively); the differences in the above indictors at T 1 between the 2 groups were not statistically significant (all P > 0.05), and there were statistically significant differences in the above indictors at T 1, T 2, T 3, T 4 between the 2 groups (all P < 0.001). At T 4, the levels of serum tumor necrosis factor-alpha, interleukin-6, and interleukin-8 in group E [(93±11) ng/ml, (14.9±1.7) pg/ml, (11.4±2.2) pg/ml, respectively] were lower than those in group C [(136±15) ng/ml, (19.9±2.8) pg/ml, (15.6±4.6) pg/ml, respectively], and the differences were statistically significant ( t = 12.89, 8.40, 4.61, all P < 0.001). At T 1, the differences in the levels of inflammatory factors of both groups were not statistically significant (all P > 0.05); and the levels of inflammatory factors at T 4 were lower than those at T 1 of both groups, and the differences were statistically significantly (all P < 0.001). At T 4, the level of superoxide dismutase in group E [(66±6) U/ml] was higher than that in group C [(56±5) U/ml]. The levels of myeloperoxidase, malondialdehyde and catalase in group E [(3.0±0.4) U/g, (4.01±0.26) mmol/ml, (44±5) U/ml, respectively] were lower than those in group C [(5.7±0.7) U/g, (4.91±0.52) mmol/ml, (56±6) U/ml, respectively],and the differences were statistically significant ( t = 6.43, 18.83, 8.48, 8.74, all P < 0.001). There were no statistically significant differences in the levels of oxidative stress indicators between the 2 groups at T 1, while there were statistically significant differences in the levels of oxidative stress indicators between the 2 groups at T 1 and T 4 (all P < 0.001). The incidence of complications in group E [6.7% (2/30)] was lower than that in group C [26.7% (8/30)], and the differences were statistically significant ( χ2 = 4.32, P = 0.038). Conclusions:Esketamine can alleviate lung ischemia-reperfusion injury, improve postoperative oxygenation function, and reduce the incidence of complications.
